Elsevier

Neuroscience

Volume 65, Issue 2, March 1995, Pages 385-395
Neuroscience

Evidence of a complete independence of the neurobiological substrates for the induction and expression of behavioral sensitization to amphetamine

https://doi.org/10.1016/0306-4522(94)00524-9Get rights and content

Abstract

The repeated administration of amphetamine in rats produces behavioral sensitization which is characterized either by a progressive enhancement of the locomotor activity induced by the drug or by an enduring behavioral hypersensitivity to the drug after the cessation of the treatment. Some authors have suggested that the action of amphetamine at the level of the nucleus accumbens is responsible for the expression of behavioral sensitization, whereas the action of amphetamine at the level of the dopamine cell bodies in the ventral tegmental area induces some changes responsible for the initiation of the phenomenon. The present study fully tested this hypothesis. In two separate experiments, the effects of different doses of amphetamine repeatedly administered in the ventral tegmental area or in the nucleus accumbens were tested on the later behavioral reactivity to the administration of amphetamine in the nucleus accumbens. Independent groups of rats received five repeated administration (one injection every other day) of different doses of amphetamine either in the ventral tegmental area (0, 1, 2.5, 5 μg/0.5 μl per side) or in the nucleus accumbens (0, 1, 3, 10 μg/1 μl per side). Two days following the last intracerebral amphetamine injection, each group received a phosphate buffer solution challenge directly into the nucleus accumbens followed two days later by an amphetamine challenge (1 μg/1μl per side) in the nucleus accumbens and two days later by a peripheral challenge with amphetamine (0.5 mg/kg, s.c.). Locomotor responses were recorded following each injection. Results showed that injections of amphetamine into the nucleus accumbens induced a dose-dependent increase in locomotor activity which remained identical with the repetition of the injections. No difference between the different intra-accumbens pretreated groups was observed following the diverse phosphate-buffered saline solution and amphetamine challenges. In contrast, intra-ventral tegmental area administration of amphetamine did not produce any modification of locomotor activity. However, whereas no difference between the differently pretreated groups was observed following phosphate-buffered saline administration into the nucleus accumbens, a potentiation of the locomotor response to a challenge dose of amphetamine into the nucleus accumbens was observed which was dependent on the dose of amphetamine pretreatment into the ventral tegmental area. Similar potentiation was observed following peripheral challenge with amphetamine. Finally, cross-sensitization was observed when a challenge dose of cocaine (10 μg/1 μl per side) was injected into the nucleus accumbens, as well as when a peripheral challenge dose of morphine (2.5 mg/kg, s.c.) was administered to the ventral tegmental area-pretreated groups.

Altogether, these results demonstrate that an amphetamine action solely at the level of the dopamine cell bodies in the ventral tegmental area is necessary and sufficient to promote changes subserving behavioral sensitization, which can be later revealed by an amphetamine action at the level of the dopamine terminals in the nucleus accumbens. On the contrary, the sole amphetamine action at the level of the nucleus accumbens is not sufficient to promote these changes but is necessary to allow their expression. These findings argue for a complete dissociation for the neuroanatomical substrates which mediate the induction and the expression of the behavioral sensitization to amphetamine.

References (45)

  • T.E. Robinson et al.

    Enduring changes in brain and behavior produced by chronic amphetamine administration: a review and evaluation of animal models of amphetamine psychosis

    Brain Res. Rev.

    (1986)
  • T.E. Robinson et al.

    Persistent sensitization of dopamine neurotransmission in ventral striatum with (+)-amphetamine: a microdialysis study in freely moving rats

    Brain Res.

    (1988)
  • M. Savasta et al.

    Different neuronal location of [3H]SCH 23390 binding sites in pars reticulata and pars compacta of the substantia nigra in the rat

    Neurosci. Lett.

    (1986)
  • D.S. Segal et al.

    In vivo microdialysis reveals a diminished amphetamine-induced DA response corresponding to behavioral sensitization produced by repeated amphetamine pretreatment

    Brain Res.

    (1992)
  • H. Ujike et al.

    Lasting increase in D1 dopamine receptors in the lateral part of the substantia nigra pars reticulata after subchronic metamphetamine administration

    Brain Res.

    (1991)
  • P. Vezina

    Amphetamine injected into the ventral tegmental area sensitizes the nucleus accumbens dopaminergic response to systemic amphetamine: an in vivo microdialysis study in the rat

    Brain Res.

    (1993)
  • P. Vezina et al.

    Sensitization occurs to the locomotor effects of morphine and the specific μ opioid receptor agonist DAGO administered repeatedly to the ventral tegmental area but not to the nucleus accumbens

    Brain Res.

    (1987)
  • P. Vezina et al.

    Amphetamine administered to the ventral tegmental area but not to the nucleus accumbens sensitizes rats to systemic morphine: lack of conditioned effects

    Brain Res.

    (1990)
  • R.Y. Wang

    Dopaminergic neurons in the rat ventral tegmental area. II. Evidence for autoregulation

    Brain Res. Rev.

    (1981)
  • R.A. Wilcox et al.

    Enduring enhancement in amphetamine-stimulated striatal dopamine release in vitro produced by prior exposure to amphetamine or stress in vivo

    Eur. J. Pharmac.

    (1986)
  • A.C. Altar et al.

    Topography of substantia nigra innervation by D1 receptor-containing striatal neurons

    Brain Res.

    (1987)
  • Y. Bjijou et al.

    Evidence for a selective involvement of dopamine D1 receptors of the VTA in the behavioral sensitization induced by intra-VTA amphetamine injections

  • Cited by (0)

    View full text